AVROBIO IncNASDAQ:AVRO
- LAST PRICE1.5400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.5300/ 1
- Ask / Lots1.6200/ 50
- Open / Previous Close1.5400 / 1.5400
- Day Range
- 52 Week Range
- Volume125,163
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AVRO |
|---|---|---|
| 09:32 ET | 284 | 1.54 |
| 09:34 ET | 100 | 1.52 |
| 09:36 ET | 2324 | 1.535 |
| 09:52 ET | 3460 | 1.55 |
| 09:54 ET | 800 | 1.5407 |
| 09:57 ET | 800 | 1.54 |
| 10:01 ET | 2500 | 1.52 |
| 10:03 ET | 203 | 1.52 |
| 10:06 ET | 4447 | 1.5399 |
| 10:21 ET | 671 | 1.5399 |
| 10:30 ET | 600 | 1.54 |
| 10:35 ET | 100 | 1.55 |
| 10:37 ET | 8346 | 1.54 |
| 10:42 ET | 109 | 1.5401 |
| 10:48 ET | 400 | 1.5447 |
| 11:08 ET | 697 | 1.5407 |
| 11:11 ET | 100 | 1.54 |
| 11:13 ET | 500 | 1.545 |
| 11:15 ET | 400 | 1.545 |
| 11:22 ET | 300 | 1.5406 |
| 11:24 ET | 500 | 1.545 |
| 11:26 ET | 200 | 1.54 |
| 11:27 ET | 5523 | 1.55 |
| 11:29 ET | 3900 | 1.55 |
| 11:31 ET | 100 | 1.55 |
| 11:33 ET | 100 | 1.55 |
| 11:36 ET | 100 | 1.55 |
| 11:38 ET | 549 | 1.55 |
| 11:40 ET | 100 | 1.56 |
| 11:42 ET | 300 | 1.56 |
| 11:45 ET | 200 | 1.56 |
| 11:47 ET | 3100 | 1.56 |
| 11:49 ET | 100 | 1.57 |
| 11:51 ET | 10200 | 1.55 |
| 12:03 ET | 1300 | 1.54 |
| 12:05 ET | 400 | 1.5488 |
| 12:07 ET | 100 | 1.55 |
| 12:09 ET | 300 | 1.5422 |
| 12:16 ET | 200 | 1.55 |
| 12:23 ET | 100 | 1.55 |
| 12:27 ET | 219 | 1.55 |
| 12:36 ET | 100 | 1.55 |
| 12:38 ET | 1600 | 1.55 |
| 12:43 ET | 100 | 1.56 |
| 12:52 ET | 200 | 1.56 |
| 01:01 ET | 100 | 1.56 |
| 01:08 ET | 1400 | 1.555 |
| 01:14 ET | 100 | 1.56 |
| 01:26 ET | 741 | 1.56 |
| 01:32 ET | 2800 | 1.55 |
| 01:37 ET | 100 | 1.56 |
| 01:42 ET | 100 | 1.56 |
| 01:44 ET | 1700 | 1.55 |
| 01:50 ET | 100 | 1.555 |
| 01:57 ET | 100 | 1.56 |
| 02:06 ET | 100 | 1.56 |
| 02:09 ET | 100 | 1.56 |
| 02:11 ET | 200 | 1.555 |
| 02:20 ET | 4300 | 1.54 |
| 02:24 ET | 10690 | 1.5399 |
| 02:26 ET | 300 | 1.53 |
| 02:27 ET | 100 | 1.54 |
| 02:29 ET | 500 | 1.53 |
| 02:31 ET | 600 | 1.53 |
| 02:33 ET | 600 | 1.535 |
| 02:36 ET | 200 | 1.53 |
| 02:38 ET | 369 | 1.53 |
| 02:40 ET | 612 | 1.5306 |
| 02:42 ET | 351 | 1.53 |
| 02:44 ET | 156 | 1.53 |
| 02:45 ET | 337 | 1.53 |
| 02:47 ET | 213 | 1.53 |
| 02:49 ET | 328 | 1.53 |
| 02:51 ET | 292 | 1.53 |
| 02:54 ET | 300 | 1.53 |
| 02:56 ET | 572 | 1.53 |
| 02:58 ET | 1200 | 1.5312 |
| 03:00 ET | 443 | 1.53 |
| 03:02 ET | 1360 | 1.53 |
| 03:03 ET | 901 | 1.53 |
| 03:05 ET | 508 | 1.535 |
| 03:07 ET | 348 | 1.53 |
| 03:09 ET | 504 | 1.53 |
| 03:12 ET | 100 | 1.535 |
| 03:14 ET | 245 | 1.53 |
| 03:16 ET | 1147 | 1.53 |
| 03:18 ET | 924 | 1.53 |
| 03:20 ET | 575 | 1.535 |
| 03:21 ET | 350 | 1.53 |
| 03:23 ET | 200 | 1.53 |
| 03:25 ET | 588 | 1.53 |
| 03:27 ET | 234 | 1.53 |
| 03:30 ET | 305 | 1.53 |
| 03:32 ET | 826 | 1.53 |
| 03:34 ET | 191 | 1.53 |
| 03:36 ET | 410 | 1.53 |
| 03:38 ET | 300 | 1.53 |
| 03:39 ET | 573 | 1.54 |
| 03:41 ET | 318 | 1.53 |
| 03:43 ET | 182 | 1.53 |
| 03:45 ET | 782 | 1.53 |
| 03:48 ET | 703 | 1.535 |
| 03:50 ET | 2141 | 1.53 |
| 03:52 ET | 7203 | 1.55 |
| 03:54 ET | 600 | 1.54 |
| 03:56 ET | 500 | 1.55 |
| 03:57 ET | 5600 | 1.54 |
| 03:59 ET | 1344 | 1.54 |
Sep 25, 2023
Thinking about buying stock in SoundHound AI, Lucid Group, Limbach Holdings, Avrobio, or Consolidated Water?, from 9:31AM ET on Monday Sep 25, 2023 by Dow Jones
9:31AM ET on Monday Sep 25, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AVROBIO Inc | 68.6M | -11.1x | --- |
Tiziana Life Sciences Ltd | 68.5M | -4.5x | --- |
Zynerba Pharmaceuticals Inc | 68.5M | -1.6x | --- |
Mira Pharmaceuticals Inc | 68.7M | 0.0x | --- |
Kinnate Biopharma Inc | 69.2M | -0.5x | --- |
Eliem Therapeutics Inc | 71.0M | -1.5x | --- |
Company Information
AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. Its gene therapies employ hematopoietic stem cells that are harvested from the patient and then modified with a lentiviral vector to insert the equivalent of a functional copy of the gene that is mutated in the target disease. The Company is focusing on a group of rare genetic diseases referred to as lysosomal disorders, primarily managed with enzyme replacement therapies. Its pipeline is comprised of various HSC gene therapy programs, which include AVR-RD-02 for the treatment of Gaucher disease type 1 and type 3; AVR-RD-05 for the treatment of neuronopathic mucopolysaccharidosis type II (MPS-II) or Hunter syndrome; and AVR-RD-03 for the treatment of Pompe disease.
Contact Information
- Headquarters
- 100 TECHNOLOGY SQUARE, 6TH FLOORCAMBRIDGE, MA, United States 02139
- Phone
- 617-914-8420
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Bruce Booth
- President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer
- Erik Ostrowski
- Chief Technology Officer
- Azadeh Golipour
- Chief Business Officer
- Deanna Petersen
- Chief Medical Officer
- Essra Ridha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $68.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.53 |
EPS | $-0.14 |
Book Value | $1.72 |
P/E Ratio | -11.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
